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Abstract
Acanthamoeba is normally free-living, but sometimes facultative and occasionally opportu-
nistic parasites. Current therapies are, by necessity, arduous and yet poorly effective due to
their inabilities to kill cyst stages or in some cases to actually induce encystation. Acantha-
moeba can therefore survive as cysts and cause disease recurrence. Herein, in pursuit of
better therapies and to understand the biochemistry of this understudied organism, we char-
acterize its histidine biosynthesis pathway and explore the potential of targeting this with
antimicrobials. We demonstrate that Acanthamoeba is a histidine autotroph, but with the
ability to scavenge preformed histidine. It is able to grow in defined media lacking this amino
acid, but is inhibited by 3-amino-1,2,4-triazole (3AT) that targets Imidazoleglycerol-Phos-
phate Dehydratase (IGPD) the rate limiting step of histidine biosynthesis. The structure of
Acanthamoeba IGPD has also been determined in complex with 2-hydroxy-3-(1,2,4-triazol-
1-yl) propylphosphonate [(R)-C348], a recently described novel inhibitor of Arabidopsis thali-
ana IGPD. This compound inhibited the growth of four Acanthamoeba species, having a
50% inhibitory concentration (IC50) ranging from 250–526 nM. This effect could be ablated
by the addition of 1 mM exogenous free histidine, but importantly not by physiological con-
centrations found in mammalian tissues. The ability of 3AT and (R)-C348 to restrict the
growth of four strains of Acanthamoeba spp. including a recently isolated clinical strain,
while not inducing encystment, demonstrates the potential therapeutic utility of targeting the
histidine biosynthesis pathway in Acanthamoeba.
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Introduction
Acanthamoeba species are normally free-living, but can be accidental facultative pathogens
normally in immune competent hosts where they cause Acanthamoeba keratitis (AK). All con-
tact lens wearers are at risk of AK, which was diagnosed in 1 in 30,000 wearers in the UK [1].
Acanthamoeba are also occasionally opportunistic pathogens, causing the devastating diseases,
Granulomatous Amoebic Encephalitis (GAE) and Cutaneous Acanthamoebiasis (CA) in
immunocompromised individuals. Treatments for all isolates and forms of Acanthamoeba
infections are far from efficient. Treatment for GAE in spite of the often extreme measures
used including surgery and cryotherapy in combination with chemotherapy are often ineffec-
tive and the disease is most frequently fatal. Treatments for AK, normally consist of combined
chemotherapy including a biguanide [(poly(hexamethylene) biguanide hydrochloride PHMB
or Chlorhexidine] and a diamidine (propamidine or hexamidine). The treatment regimen is
necessarily arduous with the preparations being administered hourly for the first two days and
nights, before eliminating night time treatments for a further 2 days. A further 3–4 weeks of
treatment is required with applications made every 2 hours during the day [2,3]. The treatment
has been associated with toxic keratopathy. Despite this ordeal, therapeutic keratoplasty can
still be required and many patients are left with significant visual impairment with 2% of
patients becoming blind [3]. Therefore, there is an urgent need for improved medicines to
eliminate Acanthamoeba infections.
Histidine is an essential amino acid that humans must acquire through their diet. However,
bacteria, fungi and plants are histidine autotrophs and their histidine biosynthesis pathways
have been extensively characterised [4,5]. Histidine is generated through ten enzymatic steps,
transcribed by genes with different molecular arrangements between different taxa, making it
an interesting pathway to study these evolutionary processes. The availability of the Acantha-
moeba transcriptome [6] led to the identification of the enzymes in the histidine biosynthesis
pathway in this organism and has thus provided the tools to further study their molecular
arrangement in Acanthamoeba species.
Histidine biosynthesis has previously been identified as an attractive target for the develop-
ment of novel herbicides. Imidazoleglycerol-Phosphate Dehydratase (IGPD, EC 4.2.1.19) is
inhibited by 3-amino-1,2,4-triazole (3AT), as well as the experimental herbicide, (R)-2-
hydroxy-3-(1,2,4-triazol-1-yl) propylphosphonate, (R)-C348 and other compounds including
Č-Carboxamido phosphates and Pyrrole aldehydes [7–11]. In this study, we demonstrate that
Acanthamoeba is a histidine autotroph with the ability to scavenge this amino acid from the
environment. Furthermore, we confirm that A. castellanii and A. polyphaga have a unique hep-
tafunctional polypeptide encoding seven (7) enzymes of histidine biosynthesis including Imi-
dazoleglycerol Phosphate Synthase/cyclase, Phosphoribosylformimino-5-aminoimidazole
carboxamide ribonucleotide (ProFAR) isomerase, Phosphoribosyl-AMP Cyclohydrolase,
Phosphoribosyl-ATP Pyrophosphatase, Histidinol Dehydrogenase and ATP Phosphoribosyl-
transferase. We further demonstrate that known inhibitors of IGPD, 3AT and (R)-C348, act to
restrict the growth and development of Acanthamoeba and we determine the structure of the
complex between Acanthamoeba IGPD and the most potent inhibitor, (R)-C348, to analyse
the molecular basis of its potency.
Materials and methods
Maintenance of Acanthamoeba
The A. castellanii Neff (ATCC 30010) was originally obtained from Dr. Keith Vickerman (Uni-
versity of Glasgow, United Kingdom) and a Clinical T4 isolate of A. castellanii was obtained
Targeting histidine biosynthesis inhibits Acanthamoeba
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from Dr. Antonella Mattana [12] (University of Sassari, Italy). A. castellanii (ATCC 50370)
and A. polyphaga (ATCC 50371) were both acquired from the American Type Culture Collec-
tion (LGC standards, UK). Acanthamoeba trophozoites were routinely grown axenically at
room temperature in 2% mycological peptone (Oxoid, United Kingdom) and 0.9% maltose
(Sigma, Poole, United Kingdom) supplemented with 100 U/ml of penicillin and 100 mg/ml
streptomycin (Sigma, Poole, United Kingdom) (Clinical T4 isolate, ATCC 50370, and ATCC
50371), or with 100 U/ml of penicillin, 100 mg/ml streptomycin and 125 μg of amphotericin B
(Sigma, Poole, United Kingdom) (Neff isolate). The trophozoites were harvested by mechani-
cal detachment and collected via centrifugation at 1200 g at 4 ˚C for 5 minutes and re-sus-
pended in fresh medium. The trophozoites were incubated at room temperature in 75 cm2
corning tissue culture flasks (Corning, Amsterdam, The Netherlands).
Maintenance of Acanthamoeba in a defined medium lacking histidine
All species of Acanthamoeba were acclimatized to growth in the absence of histidine by
sequential passage into increasing concentrations (50%, 80% 100%) of the defined M11
medium, originally described by Shukla et al., [13] modified by the omission of histidine
(Table 1).
Bioinformatical analysis
Genes encoding the histidine biosynthesis enzymes were identified in GenBank™ (http://www.
ncbi.nlm.nih.gov/genbank) by word search (histidine AND Acanthamoeba) and the pathway
was constructed using the KEGGmetabolic pathway (http://www.genome.jp/kegg/pathway/
map/map01100.html). Genes identified were also compared in the Acanthamoeba castellanii
Neff genome project from Baylor College of Medicine (http://www.hgsc.bcm.tmc.edu/
microbial-detail.xsp?project_id=163).
Table 1. Composition of histidine deficient modified M11 medium per litre.
M11 Mediu—Histidine & Aromatic amino acids
Amino Acids Concentration (g/L) Trace Elements Concentration (mg/L)
L-Arginine.HCl 0.825 ZnSO4.7H2O 1
L-Leucine 0.9 MnCl2.4H2O 2.3
L-Isoleucine 0.6 (NH4)Mo7O24.4 H2O 0.4
L-Glycine 1.5 CoCl2 0.017
L-Lysine.HCl 1.25 CuSO4.5H2O 0.0033
L-Threonine 0.5 H3BO3 0.1
L-Valine 0.7 Na2EDTA 0.01
L-Methionine 0.3
Salts Vitamins Concentration (mg/L)
MgSO4.7H2O 0.985 Biotin 0.25
CaCl2.2H2O 0.0588 B12 0.00125
(NH4)2SO4FeSO4.6H2O 0.0196 Thiamine.HCl 1.25
Na2HPO4.2H2O 0.445
K2HPO4 0.34 Other Mass (g/L)
Sodium Citrate 1 Glucose 36
All components were supplied by Sigma, Poole, United Kingdom.
https://doi.org/10.1371/journal.pone.0198827.t001
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RNA extraction
Acanthamoeba were cultured and harvested as normal in modified M11 medium as described
in Table 1, the cells were counted using a Neubauer counting chamber (VWR international,
Leicestershire, UK) and were adjusted to 2 x 106 cells/ml for the extraction. Total RNA was iso-
lated using the RNA extraction kit (Agilent, Cheshire, UK) as per manufacturing instructions
and stored at -80 ˚C until required for cDNA synthesis. The integrity and purity of the RNA
was accessed via PCR and gel electrophoresis on a 2% agarose gel. The concentration was
determined via measuring absorbance on a NanoDrop (NanoDrop 2000 UV-Vis Spectropho-
tometer, Thermo Scientific).
Complementary DNA (cDNA) synthesis
Complementary DNA (cDNA) was synthesised from Acanthamoeba RNA, using Affinity-
Script™ (Stratagene, Cambridge, UK) as per manufacturer’s instructions. In brief, 2 μg of
Acanthamoeba RNA was added to 1 μl of random primers (Promega, UK) and molecular H2O
(Invitrogen, UK) to make a final volume of 14.2 μl and incubated at 65 ˚C for 5 minutes to
allow the primers to bind followed by cooling at room temperature for 10 minutes. 2 μl of Affi-
nityScript™ reverse transcriptase (RT) buffer, 2 μl of DTT, 0.8 μl of dNTP and 1 μl of Affinity-
Script™ RT was added to each tube (all reagents, unless otherwise stated, were obtained from
Stratagene, Cambridge, UK). All samples were incubated at 55 ˚C for 60 minutes and 70 ˚C for
15 minutes to inactivate the reaction. Synthesised cDNA was stored at -20 ˚C until required
for testing/amplification of genes.
Polymerase Chain Reaction (PCR)
PCR was performed to verify the gene encoding Imidazoleglycerol-Phosphate Dehydratase
(IGPD) and the heptafunctional gene encoding Histidinol Dehydrogenase, Imidazoleglycerol
Phosphate Synthase/Cyclase, Phosphoribosylformimino-5-aminoimidazole carboxamide ribo-
nucleotide (ProFAR) isomerase, Phosphoribosyl-AMP Cyclohydrolase, Phosphoribosyl-ATP
Pyrophosphatase, Histidinol Dehydrogenase and ATP Phosphoribosyltransferase oligonucleo-
tides are listed in Table 2. All standard PCR reactions were performed in a volume of 25 μl.
Each reaction contained 12.5 μl 2 X Reddymix™ (0.625 units of Thermo-Start™ Taq DNA Poly-
merase, 1 X Thermo-Start™ high performance buffer, 1.5 mMMgCl2, 0.2 mM each of dATP,
dCTP, dGTP and dTTP) (ThermoFisher, Rugby, UK), 0.5 μl of forward and 0.5 μl of reverse
oligonucleotide primers, 10.5 μl of molecular water (Invitrogen, Paisley, UK) and 1 μl of
Acanthamoeba cDNA. PCR was performed with initial denaturing at 95 ˚C for 3–4 minutes
followed by 35–40 cycles of denaturing at 95 ˚C for 30 seconds, annealing at 52–64 ˚C for 45
seconds and extension at 72 ˚C for 1 minute. With a final extension at 72 ˚C for 10 minutes,
the samples were held at 4–10 ˚C until analysis. PCR amplified DNA fragments were cloned
into the pSC-A Strataclone cloning vector (Stratagene, Cambridge, UK) according to manu-
facturer’s instructions. Sequencing of PCR amplified products was performed by Source Bio-
science (Motherwell, UK) and sequences were assembled and analysed using Sequencher™
(GeneCodes, USA) version 4.1.
Maintenance of prostate cancer cell line
AHuman Prostate Cancer Cell line (PC3-luc), genetically modified with insertion of a lucifer-
ase gene, was kindly donated by Dr. Christine Dufes (University of Strathclyde, Glasgow, UK).
PC3-luc cells were cultured in RPMI 1640 (Lonza, Slough, UK) with sodium bicarbonate and
L-glutamine supplemented with 10% heat inactivated fetal bovine serum (Biosera, Ringmer,
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UK), with 100 U/ml of penicillin, 100 mg/ml streptomycin and 125 μg of amphotericin B
(complete medium). PC3-luc were incubated at 37 ˚C, 5% CO2 in 75 cm
2 tissue culture flasks
(Corning), until the cells were 90–95% confluent. For sub-culturing, TrypLE™ Express enzyme
cell detachment medium (Life technologies, Paisley, UK) was used to remove the cells from
the culture flasks. The cells were collected by centrifugation at 1200 g at 4 ˚C.
Acanthamoeba trophozoite inhibition assays
Acanthamoeba isolate growth was standardised by seeding varied known concentrations of
amoebae in triplicate as previously described [13]. Optimal seeding concentrations were found
to be A. castellanii Neff 8 x 105 cells/ml, A. castellanii Clinical T4 isolate 1 x 106 cells/ml, A. cas-
tellanii ATCC 50370 2 x 106 cells/ml and A. polyphaga ATCC 50371 8 x 105 cells/ml in 50 μl of
the histidine deficient M11 medium. Histidine biosynthesis experimental inhibitors were
assessed by a modified version of the colorimetric microtiter plate assay described by McBride
et al., [14]. Inhibitors were dissolved in modified M11 medium deficient in histidine (Table 1),
at final screening concentrations ranging from 980 nM to 4 mM for 3AT and 30 nM to
625 μM for (R)-C348. Inhibition was assessed via doubling dilutions and a final total well vol-
ume of 100 μl. Control wells were supplemented with 50 μl of modified M11 media or 6.25 μM
final concentration of Chlorhexidine (Sigma), a concentration that was found to rupture the
cell membrane of the amoebae. The assays were incubated at 23 ˚C in an Exo-Terra thermo-
electric reptile egg incubator (Amazon, UK) for 72 hours. 10 μl of alamarBlue™ reagent (AbD
Serotec, UK) was added to each well at 48 hours and further incubated at room temperature
for 24 hours, in darkness. Absorbencies were read on spectromax (Molecular devices) at
OD570 and OD600.
The percentage inhibition of alamarBlue™ was calculated as previously described described
by McBride et al., [14].
Table 2. Primers used for the amplification of Imidazoleglycerol-Phosphate Dehydratase (IGPD) and histidinol dehydrogenase.
Primer Sequences (5’-3’) Length (bp)
Imidazoleglycerol-Phosphate Dehydratase (IGPD) Amplification
HisB_For ¶ &&7&&77&&$$&&&$77&* ¶ 19
HisB_Rev ¶ &7*777&7*77**7**$&* ¶ 19
Ac_IGPD_F ¶$&*$7&*$7**$$$$*$***$**&$&¶ 26
Ac_IGPD_R ¶*&**&**$7&&7&$&7&*$*7$&*&&&77¶ 29
HisB_For_EXP ¶ $7**$$$$*$***$**&$&$**7** ¶ 25
HisB_Rev_EXP ¶ 7&$&7&*$*7$&*&&&77**7*& ¶ 23
Histidinol Dehydrogenase Amplification
His_Dehy_F1 ¶ &&**&$*$&$*7$$$$&$&$*& ¶ 22
His_Dehy_R1 ¶ &&*7$7&$7$*&&&*$&&*&*7&&& ¶ 25
His_Dehy_F2 ¶ **&&$$**$**&&*7*&7&&*& ¶ 22
His_Dehy_R2 ¶ **&*&**7*$&$*$$*&&&7**&&** ¶ 26
His_Dehy_F3 ¶ **&*&$$***&*$*$&&$*&**&* ¶ 24
His_Dehy_R3 ¶ **&$*&*$7**&&7*&*&&&& ¶ 21
His_Dehy_F4 ¶ &*&$7&*&&&$$&&&**&$&&&*¶ 23
His_Dehy_R4 ¶ ***$***&*$$*77*$7*$&&$&&* ¶ 25
His_Dehy_F5 ¶ *&*&&7&*7&&&&$$**$&&$** ¶ 23
His_Dehy_R5.1 ¶ **&7&*7**77*$7*$7*&** ¶ 21
All sequences are supplied in 5’ to 3’ format.
https://doi.org/10.1371/journal.pone.0198827.t002
Targeting histidine biosynthesis inhibits Acanthamoeba
PLOS ONE | https://doi.org/10.1371/journal.pone.0198827 July 3, 2018 5 / 19
Where O1 is 80,586 (molar extinction coefficient of oxidised alamarBlue™ at 570 nm); O2 is
117,216 (molar extinction coefficient of oxidised alamarBlue™ at 600 nm); A1 is the absorbance
of untreated control wells at 570nm; A2 is the absorbance of untreated control wells at 600
nm. These absorbance values were multiplied by 100 to give percentage of alamarBlue™ reduc-
tion comparison to untreated controls.
The results were expressed as a mean for each triplicate ± the standard error (SE) (AbD Ser-
otec, alamarBlue™ Assay) the values described is the mean of three independent experiments.
Acanthamoeba trophozoite rescue assay
Varying concentrations of exogenous histidine was added to histidine deficient medium in
concentrations of 0.1 μM to 10 mM. Inhibitors were used at concentrations equivalent to IC90
to confirm the specificity of each inhibitor for IGPD.
Cytotoxic effects of inhibitors on a prostate cancer cell line (PC3-luc) by in-
vivo imaging system (IVIS) measuring bioluminescence
50 μl of PC3-luc were seeded at 1 x 106 cells/ml in a 96 well tissue culture plate (Greiner
bio-one, Stone house, UK), in the presence of varying concentrations of inhibitors or 1% Tri-
ton X (Sigma, Poole, UK) as a positive cytotoxic control. Inhibitor concentrations were from a
maximum of 4 mM to 125 μM. Incubation was at 37 ˚C, 5% CO2 for 72 hours. At the 72 hour
time-point 0.6 mg/ml (final concentration) of D-luciferin firefly potassium salt (Caliper Life
sciences, Cheshire, UK) was added to each well. Disruption to PC3-luc was assessed under
Xenolight IVIS (Caliper Life sciences, UK) measuring the total flux of photons/second and
Bioluminescence of the cells.
Selectivity index determination
Using dose response assays for each inhibitor against amoebae and a counter screen for cyto-
toxicity against the mammalian cell line PC3-luc (human prostate cancer cell line) a selectivity
index (SI) was calculated. The SI is the ratio of the IC50 against PC3-luc / by the IC50 against
Acanthamoeba.
Statistical analysis
The Student Paired 2 tailed T-test was used to assess the statistical significance using Minitab
16 software. Statistical significance is P< 0.05.
Acanthamoeba IGPD (Ac_IGPD) expression, purification and
crystallization
The gene encoding for Acanthamoeba IGPD (Ac_IGPD) was PCR amplified (25 cycles, Tm
64 ˚C in 10 x HF buffer) (NEB) from the pSC-A Strataclone cloning vector using Phusion
high-fidelity polymerase (NEB) and a pair of synthetic oligonucleotide primers, Ac_IGPD_F
and Ac_IGPD_R (Eurofins) (Table 2). The primers encoded for 5’ NcoI and 3’ BamHI restric-
tion sites, facilitating restriction (1 hour at 37 ˚C) (NEB) and ligation into a pET24d expression
vector (Novagen) (1 hour at 25 ˚C) using T4 ligase (NEB). Sequencing was used to validate the
clones (Gene Services, University of Sheffield). The final vector was transformed into chemi-
cally competent BL21 DE3 expression strain E. coli cells (Novagen) and recombinant protein
was expressed in Luria Broth supplemented with 50 μg/ml Kanamycin and 5 mMMnCl2 for 4
hours at 37 ˚C after induction with 1 mM IPTG. Cells were harvested by centrifugation and
the cell pellets were frozen at -20 ˚C.
Targeting histidine biosynthesis inhibits Acanthamoeba
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For purification of the recombinant protein, cell pellets were defrosted in 40 mM Tris-HCl
pH 8.0 and 2 mM EDTA and then sonicated (3 x 20 second bursts on ice) to break open the
cells. Cell debris was removed by centrifugation at 70,000 g for 10 minutes and the cell free
extract was applied to a 5 ml DEAE Fast Flow column (GE Healthcare). Protein was eluted
over a 50 ml gradient from 0–0.5 M sodium chloride in 40 mM Tris-HCl pH 8.0 and 2 mM
EDTA. Ac_IGPD fractions were combined and the protein was precipitated with 2 M ammo-
nium sulphate. Precipitate was pelleted by centrifugation at 45,000 g for 5 minutes and dis-
solved in 1 ml of 40 mM Tris-HCl pH 8.0 and 2 mM EDTA. Size exclusion chromatography
was performed using a 16 x 600 HiLoad Superdex 200 column (GE Healthcare) with 50 mM
Tris-HCl pH 8.0 and 0.5 M sodium chloride. Pure protein was concentrated to 7.5 mg/ml and
buffer exchanged into 50 mM bis-tris propane pH 7.0, 50 mMNaCl and 0.4 mMMnCl2, prior
to the addition of 2 mM (R)-C348, which was dissolved in water and adjusted to pH 7.0 by the
drop-wise addition of 5 M KOH.
Automated crystallisation trials were carried out on a Matrix Hydra II crystallisation robot
using commercial screens (Nextal, Qiagen). Cuboid-shaped crystals were grown in 0.2 M cal-
cium acetate and 20% (w/v) PEG3350 over a number of weeks, the crystals were cryoprotected
in their mother liquor with an additional 25% ethylene glycol, before being plunge cooled in
liquid nitrogen. A single crystal was mounted on a 100 K liquid nitrogen cold stream on beam-
line i03 at the Diamond Light Source. 1.79 Å data were collected at an X-ray wavelength of
0.97630 Å. The data were processed in Xia2 [15–18], revealing that the crystal belonged to the
spacegroup C2 with cell dimensions of a = 167.69 Å b = 156.1 Å c = 117.12 Å ċ = č = 90˚ Č =
125.42˚. The structure was determined by molecular replacement in Phaser (ccp4i) using a
monomer of Arabidopsis thaliana IGPD2 (At_IGPD, PDB code: 5EKW) as a search model,
which had been modified by Sculptor (Phenix) [19] to truncate any unconserved sidechains to
the CČ atom. The asymmetric unit was comprised of 12 subunits of Ac_IGPD, which had only
subtle differences in conformation (Mean rmsd for equivalent Cċ atoms 0.18 Å), with the (R)-
C348 inhibitor having the same mode of binding in each of the 12 active sites (S7 Fig). The
structure was built in COOT [20] and restrained refinement was carried out with isotropic
Bfactors using Refmac5 (ccp4i), with ligand coordinates generated in JLigand [21,22] The
structure was validated in COOT and Molprobity [20,23]. Unless otherwise stated, figures
were generated with Pymol (DeLano), superpositions were carried out in Superpose (ccp4i) by
secondary structure matching, and maps were generated using FFT (ccp4i) [24,25].
Results
PCR amplification confirms Acanthamoeba species have a novel gene
encoding seven enzymatic activities
A putative gene encoding seven histidine biosynthesis enzymes, imidazoleglycerol-phosphate
synthase/cyclase, Phosphoribosyl-Formimino-5-Amino-1-Imidazole-Carboxyamide Ribotide
(ProFAR) Isomerase, phosphoribosyl-AMP cyclohydrolase, phosphoribosyl-ATP pyropho-
sphatase, histidinol dehydrogenase, ATP phosophoribosyltransferase was identified in the
transcriptome11 with Accession number XM_004333465. PCR of five overlapping sections of
this gene verified its presence in A. castellanii Neff (Accession number MF062697) and A.
polyphaga ATCC 50371 (Accession number MF062696) (S1 Fig). Acanthamoeba has a novel
molecular arrangement which is unlike previous gene fusions identified in Escherichia coli,
Thermococcus onnurineus, Saccharomyces cerevisiae and Arabidopsis thaliana (Fig 1b)
[4,5,26,27]. The Histidinol dehydrogenase protein shares 51% identity with Thecamonas tra-
hens (Amastigomonas), 50% identity with Salpingoeca rosetta (Choanoflaggellate) and 58%
identity withMonosiga brevicollis (Choanoflaggellate) (S2 Fig).
Targeting histidine biosynthesis inhibits Acanthamoeba
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Fig 1. Histidine biosynthesis.Histidine biosynthetic pathway (a). Molecular arrangement of the histidine biosynthesis genes in bacteria (Escherichia
coli), archaea (Thermococcus onnurineus), yeast (Saccharomyces cerevisiae),Acanthamoeba species (Acanthamoeba castellanii) and plant (Arabidopsis
thaliana) (b).
https://doi.org/10.1371/journal.pone.0198827.g001
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Acanthamoeba species have a highly conserved canonical IGPD
The gene encoding IGPD was initially amplified using degenerate PCR and a combination of
5’ and 3’ RACE (Accession number ABB22879). The full-length sequence was identified in the
A. castellanii transcriptome [6] with Accession number ELR20334 and amplified from the four
Acanthamoeba species (Acanthamoeba castellanii Neff, A. castellanii Clinical T4, A. castellanii
ATCC 50370 and A. polyphaga ATCC 50371 nucleotide Accession numbers KT581992,
KT581993, KT581994, KT581995, respectively). Comparison of the nucleotide sequences
reveals a number of synonymous substitutions. The predicted ORF of Acanthamoeba IGPD
gene is 594 nucleotides in length and codes for a putative protein of 197 amino acids with a
predicted molecular weight of 21.4 kDa. ClustalW alignments reveal the protein has 100%
identity between the species (S3 Fig). The IGPD protein shares 70% identity withMixia
osmundae (fungi), 68% identity with Guillardia theta (cryptophytes), 67% identity with Rho-
dosporidium toruloides (yeast) and 66% identity with Sporisorium reilianum (fungi) (S4 Fig).
The IGPD inhibitor 3-amino-1,2,4-triazole (3AT) restricts the growth of
Acanthamoeba species in vitro
Using the standardised cell number for each isolate of Acanthamoeba, the ability of 3AT was
assessed to inhibit the growth and development of Acanthamoeba spp. Trophozoites were
grown in histidine deficient medium and inhibition assays were performed over a period of 72
hours with alamarBlue™ present for the last 24 hours. The known membrane trophocidal com-
pound, chlorhexidine was used at 6.25 μM as a positive control. 3AT was found to significantly
restrict the growth of all isolates of Acanthamoeba in a dose dependent manner at concentra-
tions of greater than or equal to 7.8 μM (P< 0.05) (Fig 2). The IC50 for each of the strains
were: A. castellanii Neff, 105 μM; A. castellanii Clinical T4, 113 μM; A. castellanii ATCC 50370
125 μM and A. polyphaga ATCC 50371 55 μM (Fig 2a).
Fig 2. 3AT inhibition, rescue and cytotoxicity. Acanthamoeba growth was significantly (P< 0.05) inhibited from
7.8 μMby 3AT (a). Through the addition of increasing concentrations of exogenous histidine (end product)
trophozoite growth was rescued and the effects of 3AT’s IC90 effect were ablated when 1 or 10 mM of exogenous
histidine is added (b). Cytotoxicity of 3AT on a human prostate cancer cell line genetically modified with the luciferase
gene (c). Bioluminescence or total flux [p/s] was detected using a Xenogen camera In-Vivo imaging system (IVIS). a,
b & c are examples of the results obtained from 3 separate runs of each isolate and species carried out in triplicate, the
table summarises all species and isolates screened. Curve fitting using nonlinear regression was carried out using
DataAspects Plate Manager analysis software to obtain IC50 and IC90 values. Significance was determined through the
paired t test.
https://doi.org/10.1371/journal.pone.0198827.g002
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All isolates of Acanthamoeba trophozoites were rescued from the effects of 3AT at 4 mM
(IC90 concentration) by the addition of exogenous histidine at concentrations of 1 or 10 mM
(Fig 2b).
3AT is non-toxic to mammalian cells at concentrations that effectively
inhibit Acanthamoeba species
Concentrations of 3AT ranging from the IC90 were tested for toxicity against mammalian cells
using the human prostate cancer cell line (PC3-luc) genetically modified to express the lucifer-
ase gene. No significant cytotoxic effects were observed with the inhibitors used in this study
at the concentrations examined (Fig 2c). The Selectivity Index was found to be> 32 for all
isolates.
The crystal structure of A. castellanii (Ac_IGPD) in complex with (R)-C348
The structure of A. castellanii IGPD in complex with (R)-C348 was determined to 1.79 Å reso-
lution (PDB: 6FWH) (See Table 3 for data collection and refinement statistics), revealing that
the enzyme forms the classic 432 symmetrical ~500 kDa spherical particle, comprised of 24
subunits, that is typical of all known IGPD enzymes (Fig 3a) [27–30]. The conservation of the
oligomeric state is critical for positioning the two imperfectly repeated metal binding motifs
(D/NXHHXXE) from each subunit on the molecular two-fold axes of the particle, generating
the 24 active sites that each contain two octahedrally coordinated manganese (II) ions (Fig 3c).
The monomer also shares the typical IGPD duplicated fold [31], with a bundle of 4 ċ-helices
sandwiched between two anti-parallel Č-sheets (S5 Fig). Within the active site the inhibitor
(Fig 3b and S7 Fig) binds with its N-linked 1,2,4-triazole ring positioned between the two man-
ganese ions, with the N2 and N4 nitrogen atoms residing within the coordination sphere of
Mn1 and Mn2, respectively. The C3-OH substituent group of the inhibitor acts as a second
non-protein ligand to Mn1, with the sixth ligand position around Mn2 being occupied by a
water molecule (HOH1) that has been proposed to have a key role in accepting a proton from
the substrate’s imidazole ring during the initial stages of the reaction catalysed by IGPD [32].
The residues from the metal binding motifs complete the coordination of each metal ion;
Mn1; H67A’, H40A, H162A and E166A and Mn2; H66A’, E70A’, H138A’, H163A with a Mn-
Mn distance of 6.6 Å. The phosphonate group of the inhibitor sits within a predominantly pos-
itively charged pocket surrounded by residues from subunits A and C, which include K170A,
R92C and R114C, and a water-mediated interaction (HOH5) with H48A. The extensive net-
work of hydrogen bonds surrounding the phosphonate binding site is completed by S191C
and K193C from the C-terminal loop of the protein, which occupies a position that essentially
shields the active site from the external solvent. The C-terminal loop has previously been
shown to be critical for catalysis [11,32] and has a role in stabilizing the binding of the reaction
intermediates during the catalytic cycle of the enzyme [11,32]. In the Ac_IGPD/(R)-C348 com-
plex the conformation of the C-terminal loop and the interactions it makes with the phospho-
nate group of the inhibitor match those observed in previously determined complexes of
Arabidopsis thaliana_IGPD in complex with the substrate IGP [33] (S6a Fig), whose mode of
binding resembles that of the imidazolate reaction intermediate. This suggests that the (R)-
C348 inhibitor in the Ac_IGPD complex mimics aspects of the binding of IGPD reaction inter-
mediates, agreeing with similar observations that have been made in complexes of the Arabi-
dopsis thaliana_IGPD homologue with (R)-C348 [11]. In the Arabidopsis_IGPD complex,
enantiomers of (R)-C348 bind within the active site of the enzyme with mirror-image packing,
however, in the Acanthamoeba enzyme a complex with (S)-C348 could not be obtained (S6b
Fig).
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The IGPD experimental inhibitor (R)-C348 significantly restricts the
growth of Acanthamoeba species in vitro
Using the standardised cell number for each isolate of Acanthamoeba, the ability of (R)-C348
was assessed to inhibit the growth and development of Acanthamoeba spp. Trophozoites were
grown in histidine deficient medium and inhibition assays were performed over a period of 72
hours with alamarBlue™ present for the last 24 hours. The known membrane trophocidal com-
pound, chlorhexidine was used at 6.25 μM as a positive control. (R)-C348 was found to signifi-
cantly (P< 0.05) restrict the growth of all isolates of Acanthamoeba in a dose dependent
manner at concentrations of 76 nM and above. The IC50 for each of the strains were: A. castel-
lanii Neff, 440 nM; A. castellanii Clinical T4, 526 nM; A. castellanii ATCC 50370, 253 nM and
Table 3. Crystallographic data collection and refinement statistics.
Data Collection: Acanthamoeba IGPD + (R)-C348
PDB: 6FWH
Wavelength (Å) 0.9763
Resolution range (Å) 95.44–1.79 (1.84–1.79)
Space group C2
Unit cell (a, b, c (Å), ċ, Č, č (˚)) 167.69, 156.1, 117.12, 90, 125.42, 90
Total reflections 772842 (57564)
Unique reflections 228093 (16827)
Multiplicity 3.4 (3.4)
Completeness (%) 99.7 (99.9)
Mean I/σ (I) 11.0 (2.1)
Wilson B factor (Å2) 14.8
Rmerge
a 0.076 (0.535)
Rpim
b 0.058 (0.309)
Refinement:
Rfactor 14.9
Rfree 19
RMSD (bonds (Å)) 0.0108
RMSD (angles (˚)) 1.5124
No. of non-H atoms:
Protein 17838
Ligands/Metal ions 181
Water 1518
Protein residues 2338 (12 chains; A-L)
Average B factors (Å2):
Main chain 16.5
Side chains 23.3
Ligands/Metal ions 14.9
Water 24.9
Ramachandran favoured/allowed (%) 95.81/4.19
Molprobity score 1.05, 100th percentile
(N = 11263, 1.79Å ± 0.25Å)
a Rmerge = Shkl Si | Ii−Im| / Shkl Si Ii
b Rpim = Shkl
p
1/n-1Si = 1 | Ii−Im| / Shkl Si Ii, where Ii and Im are the observed intensity and mean intensity of related
reflections, respectively.
Values in parenthesis are for data in the high-resolution shell.
https://doi.org/10.1371/journal.pone.0198827.t003
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Fig 3. Crystal structure of Acanthamoeba IGPD complex. The crystal structure of Ac_IGPD in complex with (R)-
C348. (a) The 24mer structure of Ac_IGPD viewed down one of the 4-fold axes. The protein backbone is shown as a
cartoon coloured by chain and the two manganese(II) ions, positioned in each of the active sites, are drawn as purple
spheres. (b) A representative Fo-Fc difference omit map for one molecule of (R)-C348 (C = yellow, O = red, N = blue,
P = orange) is shown as a green mesh (contoured at 3 σ) (An NCS averaged omit map for the binding site is shown in
Targeting histidine biosynthesis inhibits Acanthamoeba
PLOS ONE | https://doi.org/10.1371/journal.pone.0198827 July 3, 2018 12 / 19
A. polyphaga ATCC 50371, 438 nM (Fig 4a). All isolates of Acanthamoeba trophozoites were
rescued from the effects of (R)-C348 at 625 μM (IC90 concentration) by the addition of exoge-
nous histidine at concentrations of 1 or 10 mM, (Fig 4b).
(R)-C348 is not toxic to mammalian cells at concentrations that effectively
inhibit Acanthamoeba species
Concentrations of (R)-C348 ranging from the IC90 were tested for toxicity against mammalian
cells using the human prostate cancer cell line (PC3-luc) genetically modified to express the
luciferase gene. No significant cytotoxic effects were observed with the inhibitors used in this
study at the concentrations examined (Fig 4c). The Selectivity Index was found to be> 1,188
for all isolates.
Discussion
Histidine autotrophy is limited to only certain taxa and known to include bacteria, fungi and
plants. Herein we demonstrate that A. castellanii and A. polyphaga, species are also histidine
autotrophs as they were able to grow in a defined medium, which lacks histidine. Furthermore,
S7 Fig). Beneath is a labelled schematic drawing of (R)-C348, generated in ChemDraw. (c) The active sites of Ac_IGPD
lie between three neighbouring subunits (A; cyan, A’; green and C; beige), adjacent to each of the 2-fold axes of the
protein 24mer. Two of the subunits octahedrally coordinate the two manganese ions (purple spheres) via the
imperfectly repeated metal binding motif, with the addition of a water molecule (HOH1; red sphere), which is
stabilised by D101A. The triazole ring of (R)-C348 binds between the metal ions, with the N2 and N4 atoms sitting
within the coordination sphere of Mn1 andMn2, respectively. The C2-OH group also acts as a ligand to Mn1. The
phosphonate group of the inhibitor sits in a site surrounded by a number of positively charged residues from subunit A
and C, including S191C and K193C from the C-terminal loop, which binds across the active site and buries the
inhibitor from solvent.
https://doi.org/10.1371/journal.pone.0198827.g003
Fig 4. (R)-C348 inhibition, rescue and cytotoxicity. Acanthamoeba growth was significantly (P< 0.05) inhibited
from 55 nM by (R)-C348 (a). Through the addition of increasing concentrations of exogenous histidine (end product)
trophozoite growth was rescued and the effects of (R)-C348 ablated when 1 mM histidine is added (b). Cytotoxicity of
(R)-C348 on a human prostate cancer cell line genetically modified with the luciferase gene (c). Bioluminescence or
total flux [p/s] was detected using a Xenogen camera In-Vivo imaging system (IVIS). a, b & c are examples of the
results obtained from 3 separate runs of each isolate and species carried out in triplicate, the table summarises all
species and isolates screened. Curve fitting using nonlinear regression was carried out using DataAspects Plate
Manager analysis software to obtain IC50 and IC90 values. Significance was determined through the paired t test.
https://doi.org/10.1371/journal.pone.0198827.g004
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in histidine-deficient medium the growth of both species of Acanthamoeba was inhibited by
3-amino-1,2,4-triazole (3AT) and the experimental compound 2-hydroxy-3-(1,2,4-triazol-
1-yl) propylphosphonate (R)-C348, which both specifically target IGPD [9–11]. Neither of
these two compounds showed any cytotoxicity against mammalian cells at the concentrations
used. However, 3-amino-triazole (3AT, Amitrole) has been classified as a Group B2-probable
human carcinogen and indicates that 3AT can induce tumors in the thyroid, liver and the pitu-
itary of laboratory mice and rats [33–35]. Thus the discovery of safe inhibitors of histidine bio-
synthesis is warranted. However, the specificity of 3AT and 2-hydroxy-3-(1,2,4-triazol-1-yl)
propylphosphonate (R)-C348 for histidine biosynthesis inhibition in the system used here was
proven through demonstrating their effects can be ablated by the addition of exogenous histi-
dine. Together these results demonstrate that Acanthamoeba are capable of synthesising histi-
dine de novo, but can survive by scavenging histidine when at sufficiently high levels in the
environment.
Histidine biosynthesis has been successfully targeted in plants by 3AT [10] and has been
suggested as having potential against some pathogens such asMycobacterium tuberculosis [36].
The absence of this pathway in mammals makes it an attractive proposition for new antimicro-
bials and provided the motivation for the studies described herein. The ability of (R)-C348 to
inhibit Acanthamoeba at nanomolar levels provides proof of principle of targeting this path-
way in vitro. The Selectivity Index is often used as a reference guide to prioritise the potency
of compounds for further lead optimization studies. (R)-C348 showed great selectivity to
Acanthamoeba than the PC3-luc cytotoxicity screen indicating potential use therapeutically
and/or in the prophylactic use of medical devices. We identified the minimal rescue concentra-
tion of exogenous free histidine to be 1mM, rescuing Acanthamoeba from the effects of 3AT or
(R)-C348 respectfully. Importantly, the concentration of histidine required to rescue Acantha-
moeba are significantly higher than those found in primate eyes and are therefore not likely to
present an impediment [37].
Histidine is synthesised de novo from ATP and 5-phosphoribosyl 1-pyrophosphate through
ten sequential enzymatic reactions5. The molecular arrangement of the enzymes is known to
vary between different taxa, with some bacteria such as Escherichia coli possessing 3 gene
fusions resulting in 3 bifunctional proteins, imidazoleglycerol phosphate dehydrogenase/histi-
dinol phosphate phosphatase (hisBN), imidazoleglycerol phosphate synthase/ cyclase (hisHF)
and phosphoribosyl—ATP pyrophosphatase/phosphoribosyl AMP cyclohydrolase (hisIE).
Archeabacteria such as Thermococcus onnurineus have a single hisIE gene fusion. The yeast
Saccharomyces cerevisiae has 2 gene fusionsHIS4 (corresponding to bacterial genes hisIED)
andHIS7 (corresponding to hisHF) and plants (Arabidopsis thaliana) have 2 gene fusions
HISN2 (corresponding to hisIE) and HISN4 (corresponding to hisHF) as well as gene duplica-
tion (Fig 1) [38]. In contrast, we demonstrate that A. castellanii and A. polyphaga have a novel
molecular arrangement consisting of a single gene that translates into a 1,682 amino acid pro-
tein containing seven distinct enzymatic domains (imidazoleglycerol-phosphate synthase/
cyclase, Phosphoribosyl-Formimino-5-Amino-1-Imidazole-Carboxyamide Ribotide Isomer-
ase, phosphoribosyl-AMP cyclohydrolase, phosphoribosyl-ATP pyrophosphatase, histidinol
dehydrogenase, ATP phosophoribosyltransferase) with a predicted molecular weight of 179.13
kDa.
The significance of gene fusions has been debated. While they can provide markers for evo-
lution, they can also be misleading as careful phylogenetic analyses have demonstrated that
they are likely to occur independently in multiple taxa. Furthermore, their distribution is
further influenced by horizontal gene transfer, which has been suggested to be the major route
of their dissemination [36]. The completion of further genomes and phylogenetic analyses will
be needed to cast light on the origin of the novel heptafunctional fusion. Novel molecular
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arrangements of complex pathways have previously been described for the shikimate pathway
in Acanthamoeba species, where Acanthamoeba deviates from the classical pentafunctional
AROM complex, seen in some eukaryotes (fungi & protists) to a quadriifunctional complex
[39]. Now, the data on the histidine biosynthesis pathway together with that of the shikimate
pathway, suggests that complex biosynthesis pathways are subjected to evolutionary pressures
that favour gene fusions and multi-functional polypeptides.
Through these studies, and our previous studies on the Acanthamoeba shikimate pathway
[39], a picture of the metabolism of Acanthamoeba emerges indicating that it is much
more capable and flexible than previously appreciated. Thus Acanthamoeba is capable of
de novo synthesis of histidine, tyrosine, phenylalanine and tryptophan, but is also capable of
scavenging these when available. The current study demonstrates histidine biosynthesis as a
viable antimicrobial target and provides the first information about the structure of
Acanthamoeba IGPD and its interaction with two inhibitors. The potential utility of the
inhibiting IGPD or indeed histidine biosynthesis in general for new therapeutics and or
contact lens solutions remains to be determined in future studies. The functional cellular
studies and the elucidation of the structure of IGPD described herein provide the means to
proceed with rationale design and refinement of more potent inhibitors and a system to test
them.
Supporting information
S1 Fig. Acanthamoeba speciesHisD comparison. Sequence alignments of Histidinol dehy-
drogenase from A. castellanii Neff and A. polyphaga (ATCC 50371). No differences found
between these species at an amino acid level. The release of the RNA-seq transcriptome by
Clarke et al (2013) confirms this is the correct protein sequence for A. castellanii Neff. Multiple
sequence alignments were performed using MultAlin software. High consensus value was set
to 90% and Red, low consensus value was set to 50% and Blue. Neutral consensus is in Black
[40].
(TIF)
S2 Fig.HisD protein comparison between organisms.Histidinol dehydrogenase protein
from A. castellanii Neff shares 51% identity with Thecamonas trahens (Amastigomonas), 50%
identity with Salpingoeca rosetta (Choanoflaggellate) and 58% identity withMonosiga brevicol-
lis (Choanoflaggellate). Multiple sequence alignments were performed using MultAlin soft-
ware. High consensus value was set to 90% and Red, low consensus value was set to 50% and
Blue. Neutral consensus is in Black39.
(TIF)
S3 Fig. Acanthamoeba speciesHisB comparison. Sequence alignments of IGPD from A. cas-
tellanii Neff, A. castellanii ATCC 50370, A. castellanii Clinical T4 isolate and A. polyphaga
ATCC 50371. No differences found between these species at an amino acid level. The release
of the RNA-seq transcriptome by Clarke et al (2013) confirms this is the correct protein
sequence for A. castellanii Neff. Multiple sequence alignments were performed using MultAlin
software. High consensus value was set to 90% and Red, low consensus value was set to 50%
and Blue. Neutral consensus is in Black [40].
(TIF)
S4 Fig.HisB protein comparison between organisms. IGPD protein from A. castellanii Neff
shares 68% identity with Guillardia theta (cryptophytes), 70% identity withMixia osmundae
(fungi), 66% identity with Sporisorium reilianum (fungi) and 67% identity with Rhodotorula
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toruloides (yeast). Multiple sequence alignments were performed using MultAlin software.
High consensus value was set to 90% and Red, low consensus value was set to 50% and Blue.
Neutral consensus is in Black [40].
(TIF)
S5 Fig. Conservation of IGPDmonomer. The conserved IGPD fold of the Ac_IGPD mono-
mer. The monomer shares the typical IGPD duplicated fold, with four ċ helices sandwiched
between two anti-parallel Č sheets. In (a) the monomer is coloured by secondary structure
(helices red, strands yellow and loops green), whilst in (b) the monomer in the same view is
coloured as a rainbow from the N-terminus (blue) to the C-terminus (red).
(TIF)
S6 Fig. Conservation of IGPD active sites. Conservation of the active site between Acantha-
moeba castellanii (Ac) IGPD and Arabadopsis thaliana (At) IGPD (a). A superposition of the
catalytic trimer of Ac_IGPD (beige, green, cyan) and the equivalent part of the structure in
At _IGPD (white) shows that all the residues but one (A44) are conserved and located in the
same position. Metal ions are shown in purple for Ac_IGPD and grey for At_IGPD, whilst
water molecules are shown in red and grey, respectively. The (R)-C348 bound in the Ac_IGPD
structure is yellow and (S)-C348 in the Arabidopsis thaliana_IGPD is white. A side view of the
active site (b) shows how the conservation of L100 in both enzymes would likely permit bind-
ing of both enantiomers of C348 in Ac_IGPD by mirror-image packing. All numbering is for
Ac_IGPD.
(TIF)
S7 Fig. The fit of the inhibitor to the electron density map. A stereo view of the inhibitor, R-
C348 (yellow sticks), and the two manganese ions (purple spheres) from one of the 12 subunits
in the asymmetric unit, with an NCS averaged Fo-Fc omit map (green mesh, contoured at 3
σ). The averaged map shows as very close similarity to the omit map calculated for a single
binding site (Fig 3b), indicating that all 12 crystallographically distinct subunits have equiva-
lent ligand binding sites.
(PNG)
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